Navjyot Kaur1, C R Pruthvi1, Yashpaul Sharma1, Himanshu Gupta1. 1. Department of Cardiology, PGIMER, Chandigarh 160012, India For the podcast associated with this article, please visit https://academic.oup.com/ehjcr/pages/podcast.
Abstract
BACKGROUND: Percutaneous coronary intervention (PCI) to calcified coronary lesions (CCLs) remains one of the most complex procedures. Latest modality to modify calcium, intravascular lithotripsy (IVL), has shown good safety and efficacy in preliminary research. However, it may be associated with acute complications, and as standalone therapy, is not sufficient for all CCLs. CASE SUMMARY: Eighty-two-year-old man, known case of coronary artery disease and multiple comorbidities, presented with worsening angina of 1 month duration. Coronary angiography revealed heavily calcified triple vessel disease with critical distal left main (LM) involvement. Owing to high surgical risk, he was offered intravascular ultrasound (IVUS) guided PCI with intra-aortic balloon support. While the diffuse, circumferential calcified lesions in LM and left anterior descending (LAD) artery were modified with rotablation (RA) followed by IVL with 3.5 and 3.0 mm balloons; ostial-proximal lesion in left circumflex (LCX) artery was treated with 3.0 mm IVL balloon as a standalone therapy. During second cycle of shockwave therapy in LCX, the 3.0 mm IVL balloon ruptured with type C dissection extending upto LM ostium which required emergent LM bifurcation stenting. We had a good angiographic result which was confirmed with IVUS. DISCUSSION: ntravascular lithotripsy and RA are complementary technologies in treating CCLs. Rotablation with a relatively small-sized burr is safe and can favourably modify superficial calcium which helps in smooth delivery of IVL balloon and ensures safe shockwave therapy, if required. Unselected upfront use of IVL without intravascular imaging may be associated with complications as described in this case. Published on behalf of the European Society of Cardiology. All rights reserved.
BACKGROUND: Percutaneous coronary intervention (PCI) to calcified coronary lesions (CCLs) remains one of the most complex procedures. Latest modality to modify calcium, intravascular lithotripsy (IVL), has shown good safety and efficacy in preliminary research. However, it may be associated with acute complications, and as standalone therapy, is not sufficient for all CCLs. CASE SUMMARY: Eighty-two-year-old man, known case of coronary artery disease and multiple comorbidities, presented with worsening angina of 1 month duration. Coronary angiography revealed heavily calcified triple vessel disease with critical distal left main (LM) involvement. Owing to high surgical risk, he was offered intravascular ultrasound (IVUS) guided PCI with intra-aortic balloon support. While the diffuse, circumferential calcified lesions in LM and left anterior descending (LAD) artery were modified with rotablation (RA) followed by IVL with 3.5 and 3.0 mm balloons; ostial-proximal lesion in left circumflex (LCX) artery was treated with 3.0 mm IVL balloon as a standalone therapy. During second cycle of shockwave therapy in LCX, the 3.0 mm IVL balloon ruptured with type C dissection extending upto LM ostium which required emergent LM bifurcation stenting. We had a good angiographic result which was confirmed with IVUS. DISCUSSION: ntravascular lithotripsy and RA are complementary technologies in treating CCLs. Rotablation with a relatively small-sized burr is safe and can favourably modify superficial calcium which helps in smooth delivery of IVL balloon and ensures safe shockwave therapy, if required. Unselected upfront use of IVL without intravascular imaging may be associated with complications as described in this case. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Ziad A Ali; Holger Nef; Javier Escaned; Nikos Werner; Adrian P Banning; Jonathan M Hill; Bernard De Bruyne; Matteo Montorfano; Thierry Lefevre; Gregg W Stone; Aaron Crowley; Mitsuaki Matsumura; Akiko Maehara; Alexandra J Lansky; Jean Fajadet; Carlo Di Mario Journal: Circ Cardiovasc Interv Date: 2019-09-25 Impact factor: 6.546
Authors: Emanuele Barbato; Didier Carrié; Petros Dardas; Jean Fajadet; Georg Gaul; Michael Haude; Ahmed Khashaba; Karel Koch; Markus Meyer-Gessner; Jorge Palazuelos; Krzysztof Reczuch; Flavio L Ribichini; Samin Sharma; Johann Sipötz; Iwar Sjögren; Gabor Suetsch; György Szabó; Mariano Valdés-Chávarri; Beatriz Vaquerizo; William Wijns; Stephan Windecker; Adam de Belder; Marco Valgimigli; Robert A Byrne; Antonio Colombo; Carlo Di Mario; Azeem Latib; Christian Hamm Journal: EuroIntervention Date: 2015-05 Impact factor: 6.534
Authors: María T López-Lluva; Alfonso Jurado-Román; Ignacio Sánchez-Pérez; José Abellán-Huerta; Fernando Lozano Ruíz-Poveda Journal: JACC Cardiovasc Interv Date: 2019-02-13 Impact factor: 11.195
Authors: Todd J Brinton; Ziad A Ali; Jonathan M Hill; Ian T Meredith; Akiko Maehara; Uday Illindala; Alexandra Lansky; Matthias Götberg; Nicolas M Van Mieghem; Robert Whitbourn; Jean Fajadet; Carlo Di Mario Journal: Circulation Date: 2019-02-05 Impact factor: 29.690
Authors: Adem Aksoy; Carlos Salazar; Marc Ulrich Becher; Vedat Tiyerili; Marcel Weber; Felix Jansen; Alexander Sedaghat; Sebastian Zimmer; Jürgen Leick; Eberhard Grube; Nieves Gonzalo; Jan-Malte Sinning; Javier Escaned; Georg Nickenig; Nikos Werner Journal: Circ Cardiovasc Interv Date: 2019-11-11 Impact factor: 6.546
Authors: Jonathan M Hill; Dean J Kereiakes; Richard A Shlofmitz; Andrew J Klein; Robert F Riley; Matthew J Price; Howard C Herrmann; William Bachinsky; Ron Waksman; Gregg W Stone Journal: J Am Coll Cardiol Date: 2020-10-15 Impact factor: 24.094
Authors: Ziad A Ali; Todd J Brinton; Jonathan M Hill; Akiko Maehara; Mitsuaki Matsumura; Keyvan Karimi Galougahi; Uday Illindala; Matthias Götberg; Robert Whitbourn; Nicolas Van Mieghem; Ian T Meredith; Carlo Di Mario; Jean Fajadet Journal: JACC Cardiovasc Imaging Date: 2017-08